In fact, yeast infections are among the most frequently reported side effects of this class of medications, along with urinary tract infections, increased urination, nausea, and constipation
The STEP (Semaglutide Treatment Effect in People with Obesity) trial series enrolled thousands of participants across multiple countries and produced data that reshaped how the medical community thinks about pharmacological weight management
Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026
This relatively short experience likely speaks to the very new convention of off-label prescribing of GLP-1RAs
Moreover, a total of 267 DEGs from GSH- and Glu-treated groups existed in wounding treatment, among which 126 genes were co-regulated by GSH, Glu and wounding, 81 genes were only regulated by GSH and wounding, and 60 genes were only regulated by Glu and wounding (Fig
altRx does not directly provide pharmacy services